TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›CYPH›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

CYPHERPUNK TECHNOLOGIES INC. (CYPH) financials

Income statement

CYPHERPUNK TECHNOLOGIES INC. (CYPH) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue————$1.50M$1.50M————
Revenue growth—————0.0%————
Operating income-$27.3M-$32.4M-$30.8M-$33.5M-$28.5M-$41.4M-$56.8M-$87.0M-$70.1M-$41.1M
Operating margin————-1902.6%-2761.7%————
Net income-$25.6M-$29.7M-$23.1M-$32.9M-$27.5M-$40.6M-$54.6M-$81.4M-$67.6M$4.82M
Net margin————-1834.3%-2705.8%————
EPS (diluted)—-$3.31-$2.11-$1.47-$0.63-$0.47-$4.82-$3.98-$1.81$0.07

Cash flow

CYPHERPUNK TECHNOLOGIES INC. (CYPH) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$25.3M-$22.1M-$26.0M-$26.9M-$26.0M-$35.2M-$49.0M-$43.8M-$60.3M-$43.9M
Capital expenditures$144K$64.0K—$100K——————
Free cash flow-$25.5M-$22.2M—-$27.0M——————

Balance sheet

CYPHERPUNK TECHNOLOGIES INC. (CYPH) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$793K$25.7M$16.3M$3.89M$52.1M$115M$65.5M$70.6M$47.2M$14.0M
Total assets$6.46M$29.1M$19.1M$7.45M$54.4M$118M$70.4M$72.8M$49.1M$163M
Total liabilities$36.2M$17.9M$9.90M$9.20M$7.72M$10.0M$11.5M$12.7M$14.1M$9.68M
Shareholders' equity-$100M$11.1M$9.18M-$1.75M$46.7M$108M$58.9M$60.1M$35.0M$154M
Retained earnings-$101M-$130M-$154M-$195M-$223M-$264M-$318M-$400M-$467M-$463M
Shares (wtd avg diluted)—9.19M14.4M22.6M59.3M85.8M11.3M20.4M37.6M70.7M

Every figure is extracted from CYPHERPUNK TECHNOLOGIES INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

Does CYPH pay a dividend?
CYPHERPUNK TECHNOLOGIES INC. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full CYPH analysis — verdict, score & filings →Is CYPH a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.